Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis
- 6 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Diabetologica
- Vol. 47 (1), 77-81
- https://doi.org/10.1007/s00592-009-0132-5
Abstract
Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patients unsatisfactorily controlled with multiple daily injections (MDI). Short-acting analogs are superior to regular human insulin in CSII. This meta-analysis is aimed at assessing the advantages of short-acting analog-based CSII over MDI in type 1 diabetes. Randomized clinical trials (RCTs) comparing CSII (with analogs) and MDI for at least 12 weeks in type 1 diabetic patients were retrieved, assessing between-group differences in HbA1c and incidence of hypoglycemia. A total of 11 RCTs was included in the analysis. CSII was associated with a significant improvement of HbA1c in comparison with MDI (standardized difference in mean: −0.3 [−0.4;−0.1]%; P < 0.001). No significant difference was observed in the rate of severe hypoglycemic episodes. The reduction of HbA1c with CSII was evident in trials enrolling patients with mean age greater than 10 years, but not in younger children. Available data justify the use of CSII for basal-bolus insulin therapy in type 1 diabetic patients unsatisfactorily controlled with MDI.Keywords
This publication has 25 references indexed in Scilit:
- Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetesPediatric Diabetes, 2009
- Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysisDiabetes, Obesity and Metabolism, 2009
- In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargineDiabetic Medicine, 2008
- Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitusPediatric Diabetes, 2007
- A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education aloneDiabetic Medicine, 2007
- Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control studyActa Diabetologica, 2007
- Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trialDiabetic Medicine, 2005
- A randomized, controlled study of insulin pump therapy in diabetic preschoolersThe Journal of Pediatrics, 2004
- A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin GlargineDiabetes Care, 2004
- Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapyActa Diabetologica, 2003